The strength of this study lies in its use of two-sample Mendelian randomization to investigate the bidirectional causal relationships between inflammatory bowel disease (IBD) and its subtypes (Crohn’s disease [CD] and ulcerative colitis [UC]) and the risk of breast cancer and its subtypes (ER + BC and ER-BC). The gene discussed is ESR1; the disease is breast cancer.